MAPK/ERK pathway is a critical pathway regulating glioma initiation and development via signaling moderators such as receptor tyrosine kinases (RTKs), RAS, etc. (Pandey et al., 2016). This evidence concerns the gene NTRK1 and central nervous system cancer.